H.R. 4952 would direct the Secretary of Health and Human Services to study and report to the Congress on how quality bonuses affect Medicare Advantage payment rates.
CBO estimates that the cost of this study would be less than $500,000; that spending would be subject to the availability of appropriated funds. Enacting H.R. 4952 would not affect direct spending or revenues; therefore, pay-as-you-go procedures do not apply. CBO estimates that enacting H.R. 4952 would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2029.
H.R. 4952 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act.